Views & Analysis Digital Health Round-up - Trump's reign begins A round-up of this week's digital healthcare news. Marco Ricci reports.
News Novartis less exposed to US pricing pressure, says Jimenez Europe and Asia account for a large share of company's income.
News J&J to "price responsibly", says CEO post Trump meeting Gorsky promises "transparency report" on pricing.
News Life Sciences at heart of UK’s new Industrial Strategy No guarantee of funding for new medicines funding - which is being squeezed again
News Pharma braces as Trump begins dismantling Obamacare Trump focused on reforming or repealing Obamacare
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
